Concentrix’s (CNXC) “Outperform” Rating Reiterated at Barrington Research

Barrington Research reiterated their outperform rating on shares of Concentrix (NASDAQ:CNXC) in a research report released on Monday,Benzinga reports. Barrington Research currently has a $62.00 price target on the stock.

CNXC has been the topic of several other reports. Canaccord Genuity Group reiterated a “buy” rating and issued a $80.00 price target on shares of Concentrix in a research report on Tuesday, September 23rd. Wall Street Zen upgraded Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, October 25th. Weiss Ratings upgraded Concentrix from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, January 8th. Finally, Robert W. Baird cut their price target on Concentrix from $75.00 to $62.00 and set an “outperform” rating for the company in a report on Monday, September 29th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $63.75.

Concentrix Price Performance

Shares of CNXC opened at $41.42 on Monday. Concentrix has a twelve month low of $31.63 and a twelve month high of $66.00. The company has a market capitalization of $2.58 billion, a P/E ratio of -1.99, a price-to-earnings-growth ratio of 0.52 and a beta of 0.48. The firm has a 50 day moving average of $38.50 and a 200 day moving average of $46.65. The company has a quick ratio of 1.56, a current ratio of 1.40 and a debt-to-equity ratio of 1.67.

Concentrix (NASDAQ:CNXC) last posted its earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.93 by $0.02. Concentrix had a negative net margin of 13.02% and a positive return on equity of 16.91%. The business had revenue of $2.55 billion for the quarter, compared to analysts’ expectations of $2.54 billion. During the same quarter in the prior year, the business earned $3.26 EPS. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. As a group, equities research analysts anticipate that Concentrix will post 10.11 earnings per share for the current fiscal year.

Concentrix Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 10th. Stockholders of record on Friday, January 30th will be issued a $0.36 dividend. The ex-dividend date is Friday, January 30th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 3.5%. Concentrix’s payout ratio is 30.44%.

Insiders Place Their Bets

In related news, CEO Christopher A. Caldwell bought 1,000 shares of the business’s stock in a transaction dated Friday, October 31st. The shares were purchased at an average price of $40.00 per share, with a total value of $40,000.00. Following the transaction, the chief executive officer owned 287,661 shares in the company, valued at $11,506,440. This trade represents a 0.35% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 3.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Concentrix

A number of large investors have recently bought and sold shares of the business. AQR Capital Management LLC raised its holdings in shares of Concentrix by 1.8% in the third quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company’s stock valued at $202,175,000 after acquiring an additional 75,352 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Concentrix by 18.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,939,492 shares of the company’s stock worth $89,515,000 after acquiring an additional 301,550 shares in the last quarter. State Street Corp increased its position in Concentrix by 8.7% during the 2nd quarter. State Street Corp now owns 1,622,854 shares of the company’s stock valued at $85,776,000 after purchasing an additional 130,529 shares during the period. 1832 Asset Management L.P. raised its holdings in shares of Concentrix by 3.1% in the 2nd quarter. 1832 Asset Management L.P. now owns 1,544,997 shares of the company’s stock valued at $81,661,000 after purchasing an additional 46,856 shares in the last quarter. Finally, Invenomic Capital Management LP raised its holdings in shares of Concentrix by 19.7% in the 3rd quarter. Invenomic Capital Management LP now owns 822,345 shares of the company’s stock valued at $37,951,000 after purchasing an additional 135,429 shares in the last quarter. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Key Headlines Impacting Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Strong cash generation and buybacks/dividend support valuation — Concentrix reported record operating cash flow ($807M FY2025) and adjusted free cash flow (~$626M), returned $258M to shareholders and repurchased shares in Q4; management targets $630–650M adjusted free cash flow for FY2026, which underpins the rally. Concentrix Reports Q4 and Fiscal Year 2025 Results (Quiver/Press)
• Positive Sentiment: Beat and forward guidance: revenue slightly ahead of expectations and management issued FY2026 non‑GAAP EPS guidance ($11.48–$12.07) plus Q1 guidance, signaling confidence in underlying operations and supporting upside to estimates. Concentrix Q4 Results / Slide Deck (Company)
• Positive Sentiment: Analyst support — Barrington Research reiterated an Outperform rating, which can amplify buying interest while the firm executes cash returns and guidance beats. Barrington Reiterates “Outperform”
• Neutral Sentiment: Longer‑term strategy: management is transforming the business toward GenAI, SaaS and technology-enabled services (moving beyond traditional call center work). This is strategically positive but execution/timing risk means immediate impact is uncertain. Seeking Alpha — Webhelp Write Off / Transformation
• Negative Sentiment: Large non‑cash goodwill impairment drove a GAAP operating and net loss — a $1.52B impairment pushed Q4 operating loss and FY2025 net loss, compressing GAAP margins and creating headline risk and valuation uncertainty despite healthy non‑GAAP results. That impairment is the primary negative driver for intraday volatility. GlobeNewswire — Q4/FY2025 Results
• Negative Sentiment: Margin pressure and lower non‑GAAP metrics year‑over‑year — non‑GAAP operating margin and adjusted EBITDA declined modestly y/y, and non‑GAAP EPS fell vs. prior year quarter, highlighting near‑term margin headwinds even as revenue grew. Yahoo Finance — Deep Dive on Margin Pressure

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.